Sort
35,931 grants matching “parkinsons”
Wisconsin Stem Cell Research Center
$796,841Wicell Research Institute · P20 · FY2003 · GM
Regulation of tau expression in Alzheimer disease and aging
$796,800John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AG
Magnetic-field Control of Ionic Bonds on Polar Surfaces by Design
$796,353Jiamian Hu · University Of Wisconsin-Madison · · FY2020 · ENG
An Integrated Neurochemical/Electrophysiological Recording and Neuromodulation System for Basic and Clinical Research
$795,327Kendall Lee · Navinetics Neuromodulation, Inc. · R42 · FY2024 · NS
Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI)
$795,227Wenbing Yun · Sigray, Inc. · R44 · FY2022 · GM
Whole-brain fluorescence and brightfield imaging at single-cell level
$795,074Pixuan Zhou · Dmetrix, Inc. · R44 · FY2012 · AG
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
$795,037Mark H Tuszynski · University Of California, San Diego · R01 · FY2024 · AG
Regulation Of Immune Responses In Humans and in Experimental Animals
$795,029Warren Strober · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Development of Novel SV2A PET Agents for Early Detection of Alzheimers Disease
$794,878Zhengxin Cai · Yale University · R01 · FY2018 · AG
Deep Brain Stimulation for Chronic Auditory Hallucinations in Treatment-Resistant Schizophrenia: an early-stage clinical trial
$794,858Nicola G Cascella · Johns Hopkins University · U01 · FY2023 · MH
Focused ultrasound for memory disorders
$794,543Vincent P Ferrera · Columbia University Health Sciences · R01 · FY2023 · MH
Neurotransmitter Absolute Concentration Determination with Diamond Electrode
$794,442Kendall H. Lee · Mayo Clinic Rochester · U01 · FY2016 · NS
Programming and Reprogramming Human Cells
$793,796Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2013 · CA
NeuroMAP System for Clinical Research
$793,693Gianluca De Luca · Altec, Inc. · R44 · FY2018 · NS
Changes in synaptic vesicle-binding of alpha-synuclein as an early biomarker for synucleinopathies
$793,535Jacqueline Burre · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
GM1 Ganglioside Effects on Parkinson's Disease
$793,319Thomas Jefferson University · R01 · FY2004 · NS
Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders
$793,072Jill Kreiling · Brown University · R01 · FY2023 · AG
Daily Experiences and Well-being among Caregivers for Older Adults Experiencing Lewy Body Dementia.
$792,683Karen L Fingerman · University Of Texas At Austin · R01 · FY2024 · AG
Environmental and Genetic Risks for Parkinson's Disease
$792,498Stanford University · R01 · FY2004 · NS
Neurotransmitter Absolute Concentration Determination with Diamond Electrode
$792,464Kendall H. Lee · Mayo Clinic Rochester · U01 · FY2015 · NS
Dietary Modification Of Brain Aging And Neurodegenerative Disorders
$792,392Mark Mattson · National Institute On Aging · ZIA · FY2009 · AG
Elucidating the biological differences between distinct fibrillar and non-fibrillar alpha-synuclein inclusions in human stem-cell models
$792,063Vikram Khurana · Brigham And Women'S Hospital · R01 · FY2020 · NS
Gene Expression in Long-Term Memory
$792,052Cristina M Alberini · New York University · R01 · FY2024 · MH
Academic/Industry Partnership for Next-Generation Robotically Guided Intraoperative Ophthalmic OCT
$791,994Anthony Nanlin Kuo · Duke University · U01 · FY2025 · EY
UNDERSTANDING THE ROLE OF GENE ENVIRONMENT INTERACTIONS IN THE DEGENERATION OF HUMAN DOPAMINERGIC NEURONS IN PARKINSONS DISEASE.
$791,889Brigham & Womens Hospital Inc · · FY2019 · Department of the Army